During the past decade, Universitätsklinikum Tübingen; Klinik für Urologie conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Tübingen; Klinik für Urologie" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Merck Sharp & Dohme LLC" with 3 trials sponsored, "Photocure" with 2 trials sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored and "CureVac" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Tübingen; Klinik für Urologie" #1 collaborator was "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Tübingen; Klinik für Urologie" are "Bladder Cancer" (3 trials), "Prostatic Neoplasms" (3 trials), "Renal Cell Carcinoma" (3 trials), "Metastatic Renal Cell Carcinoma" (2 trials) and "Advanced Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Tübingen; Klinik für Urologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Tübingen; Klinik für Urologie" are "Drug" (16 trials), "Biological" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (5 trials), "Enzalutamide" (3 trials), "Pembrolizumab" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Tübingen; Klinik für Urologie" are 13 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Tübingen; Klinik für Urologie". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Universitätsklinikum Tübingen; Klinik für Urologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Tübingen; Klinik für Urologie, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".